| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $300.0M | +17.1% |
| R&D Expense | $19.1M | +292.7% |
| SG&A Expense | $53.1M | +3.6% |
| Operating Income | $21.2M | +201.4% |
| Pre-tax Income | $5.4M | -95.7% |
| Income Tax | -$8.9M | — |
| Net Income | $14.3M | -88.7% |
| EPS (Basic) | $0.02 | -97.1% |
| EPS (Diluted) | $0.02 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.3M | -36.6% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $117.2M | -8.5% |
| Total Assets | $881.1M | +16.8% |
| Current Liabilities | $103.6M | +35.6% |
| Long-term Debt | $307.5M | +47.1% |
| Total Liabilities | $416.0M | +40.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $33.0M | -13.7% |
| Capital Expenditures | $127.2M | +11.8% |
| Investing Cash Flow | -$134.6M | -81.5% |
| Financing Cash Flow | $83.5M | +1315.6% |
| Free Cash Flow | -$94.2M | -24.7% |
| -97.1% |
| Stockholders' Equity |
| -$148.4M |
| +69.0% |